摘要 |
A drug registry database is administered by storing healthcare claims for a plurality of patients and providing a user interface that displays new drug/comparator drug pairings in which a new drug includes a threshold number of healthcare claims and a comparator drug with substantially similar medical indications as the new drug. Based on receiving a new drug/comparator drug pairing selection, an analysis engine identifies from healthcare claims a statistically matched first of patients having used the new drug and second group of patients having used the comparator drug; identifies a comparative occurrence of existing medical conditions or new medical conditions in the statistically matched groups; and calculates a probability value indicating a relative likelihood that a patient taking the new drug will have a medical condition from the new or existing medical conditions in comparison to a likelihood that a patient taking the comparator drug will have the medical condition.
|